DiaMetra Srl (hereafter referred to as DiaMetra) is a leading in-vitro diagnostic solution provider to the clinical laboratory market. We develop, manufacture and market innovative immunoassays to provide improved diagnostic outcomes for patients. Our immunoassay portfolio is a combination of an endocrinology testing menu and assay panels in complementary fields such as Autoimmunity and Tumor Markers. DiaMetra was founded in 1996 and, in 2014, became a part of global company Immunodiagnostic Systems Holdings Ltd.
As a leading diagnostics company, we aim to serve the needs of clinical laboratories worldwide by developing and supplying innovative solutions. Our high-quality products improve laboratory efficiency and provide fast, accurate solutions to support for diagnosis and therapy monitoring.
Our immunoassay portfolio is available as stand-alone manual test kits which are suitable for automation using many existing open platform ELISA systems. This allows our offering to meet the needs of both clinical and research laboratories of all types and sizes, with their diagnostic testing requirements.
The growing number of patients and increasing socio-economic costs in healthcare drive a need for better diagnostics and treatment monitoring tools. We are committed to developing and supplying high-quality, innovative diagnostic solutions. In partnership with laboratories, we share the common goal of providing clinicians and their patients with improved diagnostic outcomes.
Clinical and research laboratories across the world choose our high-quality assays and expertise when diagnosing, monitoring, or researching conditions to improve outcomes and enhance patient value.